comparemela.com

Latest Breaking News On - ஆய்வகம் ஆட்டோமேஷன் - Page 21 : comparemela.com

Corning to highlight newest products in 3D cell culture portfolio at SLAS2021

Corning to highlight newest products in 3D cell culture portfolio at SLAS2021 Corning Incorporated will highlight its latest technologies that support the advancement of 3D cell culture, automation, and drug discovery at this year s virtual Society for Laboratory Automation and Screening (SLAS) conference on Jan. 25 through 27. Now more than ever, tools used to facilitate scale-up, reproducibility, and consistency of 3D cell culture are helping enable critical research needed to solve the industry s most pressing problems. Corning will share the newest products in its 3D cell culture portfolio, including Matrigel ® matrix-3D plates, which can provide a more consistent, ready-to-use cell culture format to support organoid and spheroid culture models and reduce workflow steps. Also featured is Corning

Corning Life Sciences to share suite of 3D cell culture technologies at SLAS2021

 E-Mail CORNING, N.Y. Corning Incorporated (NYSE: GLW) will highlight its latest technologies that support the advancement of 3D cell culture, automation, and drug discovery at this year s virtual Society for Laboratory Automation and Screening (SLAS) conference on Jan. 25 through 27. Now more than ever, tools used to facilitate scale-up, reproducibility, and consistency of 3D cell culture are helping enable critical research needed to solve the industry s most pressing problems. Corning will share the newest products in its 3D cell culture portfolio, including Matrigel® matrix-3D plates, which can provide a more consistent, ready-to-use cell culture format to support organoid and spheroid culture models and reduce workflow steps. Also featured is Corning® Matrigel matrix for organoid culture, a vialed solution that is validated to support growth and differentiation of organoid culture and is also qualified to form stable 3D dome structures commonly used in organoid cultu

Benchling Doubles Annual Recurring Revenue (ARR) for Fourth Straight Year Amid COVID-19 Pandemic

Share this article SAN FRANCISCO, Jan. 14, 2021 /PRNewswire/ With biotech seizing headlines amid the COVID-19 pandemic, Benchling - the industry s most widely adopted life science R&D cloud - closed another record-breaking year. The company doubled its annual recurring revenue (ARR) for the fourth year in a row while adding more than 150 customers in industries spanning biopharmaceuticals, biomaterials, agriculture, renewable energy, fragrances and food. Benchling s business achievements for 2020 include: Speeding breakthroughs: Customers working on treatments for COVID-19 estimated that using Benchling shortened their time to deliver multiple antibody treatments to market by 70%. Rapidly growing customer base: Since launching in 2012, more than 270,000 scientists and 1,000 R&D organizations have adopted Benchling s cloud platform. Notable new customers added in 2020 include Gilead Sciences, Sanofi, UCB, and Corteva Agriscience.

Enabling Technologies from HEIDENHAIN to Showcase at SLAS2021

Enabling Technologies from HEIDENHAIN to Showcase at SLAS2021 -For medical and lab automation- January 13, 2021 10:14 ET | Source: HEIDENHAIN CORPORATION HEIDENHAIN CORPORATION Schaumburg, Illinois San Jose, CA, Jan. 13, 2021 (GLOBE NEWSWIRE) HEIDENHAIN is proud to showcase motion control enabling technologies at the upcoming SLAS2021 digital exposition on January 25-27.  This annual global conference and expo by SLAS (Society of Lab Automation and Screening) welcomes scientists, engineers and business leaders from academia, government and industry to immerse themselves in the latest life sciences discovery and technology research and new products that can change the world.  As a long-time world leader and provider of precision measurement and motion control components and systems, HEIDENHAIN is committed to supporting the medical technology and laboratory automation fields with state-of-the-art equipment as

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.